Anuh Pharma Limited has informed the Exchange about change in Management
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
At its 65th AGM held on August 22, 2025, Anuh Pharma shareholders approved several management changes. Mr. Bharat Nemchand Shah and Mr. Gaurav Satish Shah were reappointed as Non-Executive Non-Independent Directors under the rotation provision. Mr. Ankit Kishor Chande was reappointed as Cost Auditor for FY 2025-26. M/s. GHV & Co., Practicing Company Secretaries, was newly appointed as Secretarial Auditor for a first term of five consecutive years (FY 2025-26 to FY 2029-30). Additionally, Mr. Ritesh Bipin Shah and Mr. Vivek Bipin Shah were reappointed as Joint Managing Directors for five years effective January 8, 2026 to January 7, 2031. Ritesh and Vivek Shah are sons of Vice Chairman Mr. Bipin N. Shah.
These are routine reappointments with no disruption to leadership. The Shah promoter family continues to lead the company through both JMD roles, providing management continuity. No material change expected for shareholders or stock price.